Spike protein: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
(28 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
<StructureSection load=' | <StructureSection load='3kbh' size='340' side='right' caption='Human coronavirus NL63 spike glycoprotein (magenta) complex with its ligand ACE2 (green) (PDB code [[3kbh]])' scene='84/840522/Cv/2'> | ||
== Function == | == Function == | ||
The coronavirus '''spike protein''' (Spi, also called ''protein S'') binds the virus to its host cell via the cell's receptor: angiotensin-converting enzyme 2 (ACE2). The trimeric 2019-nCoV Spi binds to ACE2 at least 10 times more tightly than SARS coronavirus <ref>PMID:32075877</ref>. See also | |||
*[[Angiotensin-Converting Enzyme#ACEII and SARS|ACEII and SARS]]<br /> | |||
*[[SARS-CoV-2 protein S]]<br /> | |||
*[[SARS-CoV-2 spike protein mutations]]<br /> | |||
*[[Coronavirus Disease 2019 (COVID-19)]]<br /> | |||
* and the animation at [[SARS-CoV-2 protein S priming by furin]] and [[SARS-CoV-2 spike protein fusion transformation]] | |||
== Disease == | == Disease == | ||
Numerous viral diseases are causing world-shattering consequences and the current pandemic of CoVID-2019 is the recent one. | |||
== Relevance == | == Relevance == | ||
The spike protein is a key target for potential therapies and diagnostics. Various antibodies are currently being tested as potential CoVID-2019 antiviral treatment<ref>PMID:32065055</ref>. | |||
== Structural highlights == | == Structural highlights == | ||
</ | The SARS-CoV Spi receptor binding domain complex with its cellular receptor - ACE2 - shows the <scene name='84/840522/Cv/3'>interactions</scene> to ACE2 "hot spot"<ref>PMID:19901337</ref>. | ||
== See Also == | |||
*[[SARS-CoV-2 protein S]] | |||
*[[SARS-CoV-2 protein S priming by furin]] where the priming step induced by furin cleavage is '''animated'''. | |||
*[[SARS-CoV-2 spike protein fusion transformation]] with an '''animation''' and explanation of the membrane fusion mechanism. | |||
*[[SARS-CoV-2 spike protein mutations]] | |||
*[[Coronavirus Disease 2019 (COVID-19)]] | |||
*[[User:Andre Wu Le Chun/Sandbox 1|Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up]] about [[6vsb]] | |||
*[[Spike Protein (Hebrew)]] | |||
== 3D Structures of spike protein == | == 3D Structures of spike protein == | ||
[[Spike protein 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
</StructureSection> | |||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Latest revision as of 13:15, 4 December 2023
FunctionThe coronavirus spike protein (Spi, also called protein S) binds the virus to its host cell via the cell's receptor: angiotensin-converting enzyme 2 (ACE2). The trimeric 2019-nCoV Spi binds to ACE2 at least 10 times more tightly than SARS coronavirus [1]. See also
DiseaseNumerous viral diseases are causing world-shattering consequences and the current pandemic of CoVID-2019 is the recent one. RelevanceThe spike protein is a key target for potential therapies and diagnostics. Various antibodies are currently being tested as potential CoVID-2019 antiviral treatment[2]. Structural highlightsThe SARS-CoV Spi receptor binding domain complex with its cellular receptor - ACE2 - shows the to ACE2 "hot spot"[3]. See Also
3D Structures of spike proteinReferences
|
|